Insulin Resistance Testing & Breath Analysis

If you have been researching your metabolic health, you have probably come across the idea of getting an insulin resistance test. Insulin resistance sits at the root of prediabetes, type 2 diabetes, and metabolic syndrome, and it often develops silently for years before it shows up on a standard glucose test. Knowing how it is measured, what the results mean, and where the gaps are helps you make a more informed decision about your health.

This guide explains what a clinical insulin resistance test actually measures, how to interpret the results, and where breath-based metabolic testing adds a different and often earlier layer of insight.

What Is Insulin Resistance?

Insulin is the hormone that allows your cells to take up glucose from the blood and use it for energy. Insulin resistance is the condition in which muscle, liver, and fat cells stop responding efficiently to insulin. To compensate, the pancreas produces more and more insulin to keep blood glucose in a normal range.

For a while, this compensation works, and blood glucose stays normal even as insulin levels climb. That is exactly why insulin resistance can go undetected: a routine fasting glucose test can look completely normal while resistance is quietly progressing underneath. Over time, when the pancreas can no longer keep up, blood glucose rises and prediabetes or type 2 diabetes develops.

What a Clinical Insulin Resistance Test Measures

There is no single universal “insulin resistance test.” Instead, clinicians use a few different measures, each with strengths and limitations.

Fasting Insulin

A fasting insulin test measures the amount of insulin circulating in your blood after an 8 to 12 hour fast. Because insulin rises before glucose does in the progression toward diabetes, elevated fasting insulin can be an early signal of insulin resistance, even when fasting glucose is still normal. On its own, though, fasting insulin lacks universally agreed-upon reference ranges, which is why it is often combined with glucose in a calculated score.

HOMA-IR

The most widely used insulin resistance test is HOMA-IR, the Homeostatic Model Assessment of Insulin Resistance. Originally developed by Matthews and colleagues in 1985, it uses both fasting glucose and fasting insulin in a simple calculation. When glucose is measured in mg/dL, as is standard in the US, the formula is:

HOMA-IR = (fasting insulin in µIU/mL x fasting glucose in mg/dL) / 405

Both values must come from a fasted blood draw, typically in the morning. Generally, lower scores indicate better insulin sensitivity and higher scores indicate greater insulin resistance, though exact cutoffs vary between laboratories and populations, so results should always be interpreted by a clinician in the context of your overall health. Importantly, HOMA-IR is most informative in the early-to-middle stages of insulin resistance; in advanced type 2 diabetes, when insulin production falls, it can underestimate the problem.

Oral Glucose Tolerance Test (OGTT)

An OGTT measures how your body handles a standardized dose of glucose over two hours. After a fasting blood draw, you drink a glucose solution and your blood glucose (and sometimes insulin) is measured at intervals. It is a dynamic test, meaning it shows how your body responds to a glucose challenge rather than a single fasted snapshot.

The Gold Standard: The Euglycemic Clamp

In research settings, the most precise way to measure insulin sensitivity is the euglycemic-hyperinsulinemic clamp. It is highly accurate but complex, time-consuming, and impractical for routine use, which is why HOMA-IR and related measures are used in everyday practice instead.

The Gap: These Tests Tell You If, Not Why

Here is the key limitation of a standard insulin resistance test. Bloodwork can tell you whether you are insulin resistant, and roughly how far it has progressed. What it does not directly show is how efficiently your cells are actually using fuel, which is often where the earliest, most actionable signal lives.

Insulin resistance is closely tied to a concept called metabolic flexibility, your body’s ability to switch efficiently between burning fat and burning carbohydrates depending on what is available. Research consistently identifies insulin resistance as a central feature of metabolic inflexibility, which is characterized by reduced fat oxidation during fasting and a blunted ability to switch to carbohydrate oxidation when eating. In other words, poor fuel-switching often accompanies, and may precede, the blood markers a standard test captures.

This is where a different kind of measurement becomes useful.

Where Breath Testing Fits In

Breath-based metabolic testing (indirect calorimetry) does not measure insulin or glucose, so it is not a diagnostic test for insulin resistance and should not be treated as one. What it measures is different and complementary: how much of your energy is coming from fat versus carbohydrates, both at rest and across exercise intensities.

It does this through the respiratory exchange ratio (RER), the ratio of carbon dioxide produced to oxygen consumed, which reflects your fuel mix. A body that efficiently burns fat at rest and switches appropriately during activity shows good metabolic flexibility. A body stuck relying heavily on carbohydrates, unable to tap into fat efficiently, shows metabolic inflexibility, the functional pattern that so often travels alongside insulin resistance.

A PNOĒ breath test measures:

Fat and carbohydrate oxidation, showing your fuel mix directly rather than inferring it
Metabolic flexibility, how well you switch between fuel sources, which correlates with insulin sensitivity
Resting metabolic rate, your baseline energy production
VO2 max and ventilatory thresholds, markers of the cardiorespiratory fitness that strongly influences metabolic health

The honest framing is this: a blood-based insulin resistance test tells you whether insulin resistance is present. Breath testing reveals the metabolic inflexibility and fuel-utilization patterns that often accompany it, giving you a functional, actionable picture to complement, not replace, your bloodwork.

Using Both Together

The most complete approach combines them. Bloodwork (fasting insulin, HOMA-IR, or an OGTT ordered by your clinician) tells you where you stand on the clinical insulin resistance spectrum. A breath test shows how efficiently your body is using fuel and whether your metabolic flexibility is improving as you make changes to diet, exercise, and lifestyle.

That combination is powerful because metabolic flexibility responds relatively quickly to intervention. Retesting your fuel utilization over time can show whether your efforts are working, often well before a follow-up blood panel would reflect the change.

The Bottom Line

An insulin resistance test, most commonly HOMA-IR, is a valuable tool for detecting whether insulin resistance is present and roughly how advanced it is. But it tells you if, not why. Breath-based metabolic testing adds the missing functional layer: how efficiently your body burns fat versus carbohydrates, and how flexible your metabolism really is. Used together, they give you both the clinical picture and the actionable one.

If you want to understand not just whether you are insulin resistant, but how your metabolism is actually functioning, measuring your fuel utilization is the place to start.

References

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. “Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.” Diabetologia. 1985;28(7):412-419. https://pubmed.ncbi.nlm.nih.gov/3899825/
Palmer BF, Clegg DJ. “Metabolic Flexibility and Its Impact on Health Outcomes.” Mayo Clinic Proceedings. 2022;97(4):761-776. https://www.mayoclinicproceedings.org/article/S0025-6196(22)00042-8/fulltext
Tam CS, Xie W, Johnson WD, Cefalu WT, Redman LM, Ravussin E. “Defining insulin resistance from hyperinsulinemic-euglycemic clamps.” Diabetes Care. 2012;35(7):1605-1610. https://pubmed.ncbi.nlm.nih.gov/22511259/
Goodpaster BH, Sparks LM. “Metabolic Flexibility in Health and Disease.” Cell Metabolism. 2017;25(5):1027-1036. https://pubmed.ncbi.nlm.nih.gov/28467922/
Tsekouras YE, Tambalis KD, Sarras SE, et al. “Validity and Reliability of the New Portable Metabolic Analyzer PNOE.” Frontiers in Sports and Active Living. 2019;1:24. https://www.frontiersin.org/articles/10.3389/fspor.2019.00024/full